                         SEQUENCE LISTING

<110>  Kite Pharma, Inc.
 
<120>  CHIMERIC RECEPTOR T CELL TREATMENT USING CHARACTERISTICS OF THE 
       TUMOR MICROENVIRONMENT

<130>  KPI-023WO

<150>  62/656,825
<151>  2018-04-12

<150>  62/827,770
<151>  2019-04-01

<150>  62/831,946
<151>  2019-04-10

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker Sequence

<400>  1

Gly Ser Thr Ser Gly Ser Gly Lys Pro Gly Ser Gly Glu Gly Ser Thr 
1               5                   10                  15      


Lys Gly 
        


<210>  2
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  linker peptide

<400>  2

Gly Gly Gly Gly Ser 
1               5   


